Robert M. Cooper Memorial Fund

Pharmacy students listening to an instructor.

Pharmacy students who exemplify the qualities of ethics, integrity and commitment to excellence receive scholarships and awards through this fund.

Robert M. Cooper, former professor and associate dean of the School of Pharmacy, was an expert in pharmacy law. This fund, established in 1997 in his memory, is used by the chair of the Pharmacy Practice Department to award scholarships to students in the UB Doctor of Pharmacy program, and also to present an annual award to a member of the graduating class for high academic achievement in pharmacy law, and for embodying Dr. Cooper’s qualities of professionalism, ethics and integrity.

A UB faculty member since 1967, Cooper served in a variety of administrative posts at the School of Pharmacy. He was regarded as a leading authority on state and federal regulations governing pharmacy practice in New York State, and was also the editor of Pharmacy Law, published by the School of Pharmacy for New York State pharmacists.

Dr. Cooper was honored with the SUNY Chancellor’s Award for Excellence in Teaching, the Rho Chi Excellence in Teaching Award and the only honorary membership in the UB Pharmacy Alumni Association.

Other Pharmacy and Pharmaceutical Sciences Funds

News from School of Pharmacy and Pharmaceutical Sciences

  • Meaney named ACCP Fellow
    8/14/23
    Calvin Meaney, PharmD, clinical associate professor and interim division head, Division of Outcomes and Practice Advancement, Department of Pharmacy Practice, has been named a Fellow of the American College of Clinical Pharmacy (ACCP).
  • UB Center for Integrated Global Biomedical Sciences selected to host Zimbabwe Emerging Faculty Development Program
    5/18/23
    The University at Buffalo, State University of New York (UB SUNY) has been selected to be the United States host for the Zimbabwe Emerging Faculty Development Program (ZEFDP). Through a grant funded by the U.S. Department of State to the Institute of International Education, a global non-profit organization facilitating international exchange, the program will bring nine faculty from different universities in Zimbabwe to UB for six weeks beginning in early June 2023. The programmatic areas include biomedical research, pharmacy, university administration, public health, and sustainable development. 
  • Qu receives NIH grant to develop targeted mass spectrometry assays as markers in monitoring Type 1 diabetes
    9/5/23
    Jun Qu, PhD, professor, Department of Pharmaceutical Sciences, has been awarded a four-year $982,617 U01 grant from the National Institutes of Health (NIH). The study, called “Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications,” will develop novel, highly sensitive assays that quantify proteins or peptide hormones to effectively monitor the progression or efficacy of new clinical interventions prior to or following the onset of Type 1 diabetes.
  • UB School of Pharmacy and Pharmaceutical Sciences hosts 2023 Welcome Week for incoming students
    9/7/23
    BUFFALO, N.Y. – The University at Buffalo (UB) School of Pharmacy and Pharmaceutical Sciences (SPPS) welcomed incoming students during our 2023 Welcome Week, which included a multi-day orientation program, school-wide picnic and White Coat Ceremony for first year PharmD students.
  • UB Center for Integrated Global Biomedical Sciences receives NIH funding for Cloud-based Viral Surveillance Research Training Program in Jamaica
    8/9/23
    The Center for Integrated Global Biomedical Sciences at the University at Buffalo (UB), State University of New York (SUNY) has received funding to expand its Global Infectious Diseases (GID) Research Training Program. The GID is supported by the Fogarty International Center at the National Institutes of Health (NIH) for pre-doctoral and post-doctoral training that will lead to capacity building in Jamaica through UB/SUNY and the University of the West Indies (UWI) collaboration. Importantly, this new funding includes CTIS, a key cloud project implementation partner, and a women-owned small business with expertise in providing informatics solutions for clinical trials and research for over 30 years.
  • Meaney named a 2023 Outstanding Reviewer for ACCP’s Pharmacotherapy Journal
    10/6/23
    Calvin Meaney, PharmD, clinical associate professor and interim division head, Division of Outcomes and Practice Advancement, Department of Pharmacy Practice, has been named a 2023 Outstanding Reviewer for the American College of Clinical Pharmacy’s (ACCP) Pharmacotherapy Journal.
  • Gniazdowski selected for 2023-24 NACUBO Emerging Leaders Program
    10/11/23
    Kristin Gniazdowski, EdM, senior assistant dean, Finance and Administration, University at Buffalo (UB) School of Pharmacy and Pharmaceutical Sciences (SPPS) has been selected by the National Association of College and University Business Officers (NACUBO) for the 2023–24 Emerging Leaders Program.